Navigation Links
New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI
Date:6/17/2008

he most common adverse events reported are skin irritation where gel is applied, breast development or tenderness, acne, prostate enlargement, changes in lab test results, and changes in urinary habits.

Remember, this information does not take the place of the advice you get from your doctor or other health care professional. Always talk with your doctor if you have questions about AndroGel.

Unimed Pharmaceuticals, LLC., a wholly owned subsidiary of Solvay Pharmaceuticals, Inc., holds the exclusive rights to AndroGel in the United States.

About Solvay Pharmaceuticals, Inc.

Solvay Pharmaceuticals, Inc., of Marietta, Georgia is the U.S. subsidiary of Solvay Pharmaceuticals. For more information, visit http://www.solvaypharmaceuticals-us.com.

Solvay Pharmaceuticals is a research driven group of companies that constitute the global pharmaceutical business of the Solvay Group. The company seeks to fulfill carefully selected, unmet medical needs in the therapeutic areas of neuroscience, cardio-metabolic, influenza vaccines, gastroenterology, and men's and women's health. Its 2007 sales were EUR 2.6 billion and it employs more than 9,000 people worldwide. For more information, visit http://www.solvaypharmaceuticals.com.

SOLVAY is an international chemical and pharmaceutical Group with headquarters in Brussels. It employs more than 28,000 people in 50 countries. In 2007, its consolidated sales amounted to EUR 9.6 billion, generated by its three sectors of activity: Chemicals, Plastics and Pharmaceuticals. Solvay (NYSE Euronext: SOLB.BE - Bloomberg: SOLB.BB - Reuters: SOLBt.BR) is listed on the NYSE Euronext stock exchange in Brussels. Details are available at http://www.solvay.com.


'/>"/>
SOURCE Solvay Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. GeneGo is Awarded NCI Grant for Development of Systems Biology Platform for Integrative Data Analysis in Cancer
2. NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR
3. New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients
4. Abbotts Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes
5. New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease
6. Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
7. New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months
8. Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy With No Dose Limiting Toxicity in Metastatic Pancreatic Cancer
9. AlphaVax Announces Initial Analysis of Data From CMV Phase 1 Clinical Trial
10. Prospective Microbial Analysis of Bronchoalveolar Lavage Fluids with Immune Function Testing Can Distinguish Between Fungal Colonization and Fungal Disease In Lung Transplant Recipients
11. Favrille Announces Data Cutoff for Phase 3 Registration Trial of Specifid; Data Analysis and Unblinding Expected in June

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... 6 Philips Respironics applauds th...revention (CDC) to raise awareness about an import...ency. The CDC,s release of the first-ever governme...sleeplessness is a milestone in quantifying the si... educator, industry leader and sleep therapy manuf...
(Date:11/6/2009)...ewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nas...he development of small-molecule therapeutics for ...ciency virus (HIV), today reported recent accompli...r and nine months ended September 30, 2009. ,,...1104/ARDEALOGO ) ,, "Since our last quarterly u...
(Date:11/6/2009)..., N.C., Nov. 6 Chimerix, Inc., a b...e antiviral therapeutics to address life-threateni...of the company,s lead antiviral compound, CMX001, ...bal Health Security Initiative (GHSI). CMX001 is ...or the treatment of smallpox, as well as other ser...
Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Finding Raises Hope for Treating ALS 48916 1Finding Raises Hope for Treating ALS 48916 2New chemistry techniques improve hybrid scanner performance 48911 1New chemistry techniques improve hybrid scanner performance 48911 2Kimberly Clark Teams Up With Sports Legends to Launch The Depend Campaign to End Prostate Cancer 48906 1Kimberly Clark Teams Up With Sports Legends to Launch The Depend Campaign to End Prostate Cancer 48906 2Kimberly Clark Teams Up With Sports Legends to Launch The Depend Campaign to End Prostate Cancer 48906 3Kimberly Clark Teams Up With Sports Legends to Launch The Depend Campaign to End Prostate Cancer 48906 4
...age at Educational Symposium as Xoft, Launches New...ortable eBx Vehicle... Axxent(R),Electronic Brachytherapy (eBx) System, ...directly to cancer sites with minimal radiation ex...e early clinical experience with,its growing suite...
... Inc.,(Nasdaq: ENCO ), a full service multination... studies in over 30 countries for many of the worl...nies, today announced that at,this time Encorium a...iations regarding Encorium,s planned acquisition o...o companies have decided to form a strategic,partn...
Other Medicine Technology:Xoft Showcases Interim Clincal Results for Breast Cancer Product and New Indications for Electronic Brachytherapy(eBx) at Astro Meeting 2Xoft Showcases Interim Clincal Results for Breast Cancer Product and New Indications for Electronic Brachytherapy(eBx) at Astro Meeting 3Xoft Showcases Interim Clincal Results for Breast Cancer Product and New Indications for Electronic Brachytherapy(eBx) at Astro Meeting 4Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig 2Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig 3Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig 4
(Date:11/9/2009)... Corporation announces that their design, producti... Minneapolis, MN (Vocus) November 9...ing manufacturer of miniature high-rel connectors,...stems have been certified to the ISO 9001:2000 (w/... System Standard., , ,The company,s entire quality...
(Date:11/9/2009)...metic surgeons in Dallas and a “Best Physici..., has recently published his new, highly acclaimed...lastic Surgery Clinics of North America. A double-...Surgeon, Dr. Bassichis’ innovative approach ...ments to achieve the most natural, rejuvenated res...
(Date:11/9/2009)...is Bregman , a pain management physician will now...an in New York City. Patients will be able to req...-918-1629 or sending an email from davisbregman....octor in the less stressful home setting convinced...tients. The service will be fee for service cash ...
(Date:11/9/2009)...reast cancer are at higher risk of cancer recurren...cember 15, 2009 issue of Cancer , a peer-reviewed...,s results indicate that breast cancer patients wi...pies following surgery, such as radiation. , Pre...t tissue are at increased risk of breast cancer. R...
(Date:11/8/2009)...ire/ -- Today, the nation Mayors commended the U.S...ble Health Care for America Act, a historic piece ... America,s healthcare system. ,, In June, at th...ence (RI), mayors from across the nation unanimous...reducing the long-term growth of health care costs...
Breaking Medicine News(10 mins):Health News:Omnetics Connector Corporation Achieves AS9100 Certification 2Health News:Dallas Facial Plastic Surgeon Publishes Cutting-Edge Novel Approach To Facelift Technique 2Health News:Davis Bregman MD Now Offering House Calls in Manhattan 2Health News:Breast density associated with increased risk of cancer recurrence 2Health News:The Nation's Mayors Commend House Passage of Health Reform Bill 2
...reported in the capital, taking the toll to 25 Sat...hospitals.// The total number of dengue cases... victim of the mosquito-borne viral disease was 25... said medical officials. Senior officials of...
...50 years old, who hailed from Edinburgh, had died ... on animal skins. // Scrutiny by the NHS revealed ...land where Mr. Norris allegedly attended classes. ...ave come into contact with the artist. Fortunately...
...e fought with a combined treatment of hormonal the...o slow // the progress of breast cancer by over ha...se findings a call has been made for the treatment...ver the cancer for a significantly longer period t...
...drug bevacizumab (Avastin) for first time treatmen...otherapy. // This comes after a large randomised s...r, lung cancer specialist and director of Thoracic...them had received any previous chemotherapy. Half ...
...ak has forced a Canadian University to shut down a... thought to be a Norwalk-type virus that has affec...ity in New Brunswick and in the surrounding univer... on campus and they haven't found anything that le...
...ied of dengue fever in the Dominican Republic loca...authorities announced a drop in the number of deng...hit by the disease this year is nearly 4,700, out ...large number of student volunteers will be enrolle...
Other Medicine News:Health News:Dengue Claims Yet Another Victim in Delhi 2Health News:Mystery outbreak causes Canadian University to shut down 2
LM-990
FF 450plus IR
...-2000A Auto Lensmeter is designed for fast and eas... In Auto mode, the readings are automatically held...nses are automatically detected. The sophisticated... the lens. The TL-2000A has been designed with a s...
CR6-45NM Non-Mydriatic Retinal Camera
Medicine Products: